OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(-)-demecolcine
(2S)-5,7-dimethoxy-8-(2S-hydroxy-3-methyl-3-butenyl)-3',4'-methylenedioxyflavanone
(2S)-5,7-dimethoxy-8-formylflavanone
(2S)-5-Hydroxy-7-methoxy-8-[(E)-3-oxo-1-butenyl]flavanone
1,1'-(OXYDIMETHYLENE)BIS(4-FORMYLPYRIDINIUM)DIOXIME
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid
2,3-dimethoxynaphthalene-1,4-dione
2,5-hexanedione
2,6-dichlorobenzoquinone
2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid
3'-Hydroxy-HT2 toxin
3'-Hydroxy-T2 Toxin
3-(acyloxy)acyl group
3-(methylthio)propionic acid
3-hydroxyacyl derivative of bacterial toxin
3-hydroxyacyl group
3-methylarginine
4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin
4-(4-hydroxy-1,4-dimethyl-2-cyclohexen-1-yl)-3-(hydroxymethyl)-4-methyl-2-cyclopenten-1-one
4-amino-5-hydroxymethyl-2-methylpyrimidine
4-Propanoyl-HT2 toxin
5-fluoroorotic acid
5-hydroxy-7-prop-2-en-(E)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one
5-hydroxy-7-prop-2-en-(Z)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one
7-desacetoxy-6,7-dehydrogedunin
7-epi-zingiberene
A-230 nerve agent
A-232 nerve agent
A-234 nerve agent
AAL Toxin TA1
AAL Toxin TA2
AAL Toxin Tb1
AAL Toxin Tb2
AAL Toxin Tc1
AAL Toxin TC2
AAL Toxin Td1
AAL Toxin Td2
AAL Toxin Te1
AAL Toxin Te2
AAL-Toxin
Acetyl-T2 Toxin
ACRL Toxin II
ACTG-toxin A
ACTG-toxin H
aculeatol E
AF Toxin II
aflatoxin
AK-toxin I
AK-toxin II
alcuronium
aldoxorubicin
alkylating agent
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp6N3-(1->4)-beta-D-Glcp
AM-toxin I
amisulbrom
AS-I toxin
asprellic acid A
asprellic acid C
aureobasidin A
azaconazole
bafilomycin A1
BCI-215
benzene
bitertanol
Botulinum toxin type A
brevetoxin A
bromisoval
bromotopsentin
cantharidin
carbon monoxide
carminomycin
carpropamid
cassaidine
cerivastatin
cerivastatin sodium
chlormerodrin
chloroethane
chlorotoluron
ciguatoxin
ciguatoxin CTX1B
ciguatoxin CTX4B
cinchocaine
cleistanthin A
cleistanthins
clitidine
cloquintocet-mexyl
cyanotoxin
cyantraniliprole
cyazofamid
CYM-5478
cyprodinil
cytisine
D-cycloserine
D-penicillamine
decarbamoylsaxitoxin
dehydroemetine
deoxycylindrospermopsin
dextromethadone
dexverapamil
dexverapamil hydrochloride
diclocymet
difenoconazole
digoxin
dimercaprol
dimethyl diselenide
dinitrogen oxide
dinophysistoxin 1
dinophysistoxin 2
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor
edifenphos
edrophonium
edrophonium chloride
ELQ-271
environmentally persistent free radical
epoxiconazole
eriodictyol 7-O-beta-D-glucopyranoside
erucifoline
espicufolin
ethaboxam
ethotoin
ethylmercuric chloride
fat-soluble vitamin (role)
fen-G4
fendosal
fumonisin
furaltadone
furan
Gonyautoxin 5
HA15
HC toxin
hexafluoropropylene oxide trimer acid
HMT-toxin
HT-2 toxin
hycanthone
hycanthone mesylate
imibenconazole
isotrichodermol
Joro spider toxin-4
JSTX-3
kadethrin
lipid As
local anaesthetic
LOSGM1
maleic acid
maleic anhydride
meptyldinocap
mercury dichloride
metacetamol
metaldehyde
methane
methyl 5-aminolevulinate
methyl 5-aminolevulinate hydrochloride
mevastatin
microcystin-LR
mitomycin A
mycotoxin
N. meningitidis group C polysaccharide
neomycin
nephrotoxin
nereistoxin
NSC 23766
NSC 23766 trihydrochloride
ochratoxin alpha
oligomycin
P-\{alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-6-yl\}-alpha-D-GlcpNAc-(1->3)-[D-GroA-(2->1)]-alpha-D-GlcpNAc-P-6-[CH2]5NHC(=O)[CH2]4C(=O)NHR group
palytoxin
paralytic shellfish toxin
pavettamine
pectenotoxin-11
pencycuron
phaseolotoxin
phenazopyridine
phenazopyridine hydrochloride
phosphonoformic acid
phytoalexin
phytotoxin
picrotin
PM-Toxin A
PM-toxin B
PM-toxin C
poison
polychlorinated dibenzodioxines and related compounds
polymyxin
PR-toxin
propane-1,2-diol
protein synthesis inhibitor
pyrimethamine
Rac1 inhibitor
S. pneumoniae serotype 14 capsular oligosaccharide derivative
salsolinol
sarin
saxitoxin acetate
spiramycin I
T-2 toxin
T2 Toxin Triol
tabtoxin
tanespimycin
tetanus toxin (830-844)
tetraacetyl-N-azidoacetyl-D-mannosamine
tetrodotoxin
thiocyclam
tilivalline
TOP-53
toxaphene
Toxicarol
Toxiferine I
toxin
Toxin FS2
Toxin T2 tetrol
toxoflavin
Toxol
Toxyl angelate
transplatin
trisodium phosphonoformate
trisodium phosphonoformate hexahydrate
tropolone
TTK21
type Ib group B Streptococcus capsular polysaccharide
uremic toxin
uridine triacetate
urushiol III
varespladib methyl
venom
verruculogen
vibrioferrin
virulence factor
VR nerve agent
VX nerve agent
water-soluble vitamin (role)
CL: Cell Ontology
basal cell of epithelium of bronchus
bladder urothelial cell
brush cell of tracheobronchial tree
centrilobular region hepatocyte
cerebral cortex endothelial cell
cnidocyte
dendritic cell
endothelial cell of hepatic sinusoid
epithelial cell of proximal tubule
excretory cell
hepatocyte
large intestine goblet cell
lung goblet cell
M cell of gut
mast cell
periportal region hepatocyte
primary cultured cell
promonocyte
taste receptor cell
urethra urothelial cell
urothelial cell
vein endothelial cell
CMO: Clinical Measurement
blood anti-toxoplasma antibody level
blood asymmetric dimethylarginine level
blood glutathione S-transferase-mu level
blood immunoglobulin D level
blood superoxide dismutase activity level
blood symmetric dimethylarginine level
blood xenobiotic level
blood xenobiotic measurement
encephalitis incidence/prevalence measurement
infection incidence/prevalence measurement
infection onset/diagnosis measurement
infection severity measurement
lymph node measurement
lymph node-specific lymphocyte tracer radioactivity level to kidney-specific lymphocyte tracer radioactivity level ratio
lymph node-specific lymphocyte tracer radioactivity measurement
parasitic infection incidence/prevalence measurement
percentage of study population developing radiation-induced bone marrow disease during a period of time
percentage of study population developing Toxoplasma gondii brain cysts during a period of time
percentage of study population displaying Toxoplasma gondii brain cysts at a point in time
plasma anti-toxoplasma antibody level
plasma anti-toxoplasma antibody titer
plasma immunoglobulin D level
plasma superoxide dismutase activity level
post-insult time of death
post-insult time to onset of moribundity
ratio of deaths related to DMBA toxicity to total study population during a period of time
ratio of deaths related to FUDR toxicity to total study population during a period of time
renal uptake of xenobiotic
serum anti-toxoplasma antibody level
serum anti-toxoplasma antibody titer
serum glutathione S-transferase-u level
serum immunoglobulin D level
serum superoxide dismutase activity level
Toxoplasma gondii infection incidence/prevalence measurement
EFO: Experimental Factor Ontology
(-)-demecolcine
2,3-dimethoxynaphthalene-1,4-dione
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2
2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (human)
3-hydroxy-1-methylpropylmercapturic acid measurement
3-hydroxyisobutyryl-CoA hydrolase deficiency
3-hydroxypropylmercapturic acid measurement
acquired metabolic disease
Acute hepatitis
acute kidney tubular necrosis
adult intestinal botulism
alkylating agent
anthrax toxin receptor 1
anthrax toxin receptor 1 (human)
anthrax toxin receptor 2
anthrax toxin receptor 2 (human)
anti-tetanus toxoid IgG measurement
Anti-Toxoplasma gondii IgG measurement
anti-TSST-1 antibody measurement
antibody
anus
aplastic anemia
ascariasis
Ascher syndrome
Autoimmune Hepatitis
autonomic neuropathy
benzene
bladder urothelial cell
blood toxic metal amount
botulism
cantharidin
capillary leak syndrome
carbon monoxide
carcinogenicity
cardiotoxicity
carpropamid
central nervous system toxicity
cerebral toxoplasmosis
cervical dystonia
channel protein
chemotherapy-induced gastrointestinal mucositis
ciguatera poisoning
cirrhosis, familial
co-investigator
congenital toxoplasmosis
cutaneous diphtheria
D-penicillamine
decreased susceptibility to bacterial infection
delirium
dendritic cell
dermatological toxicity
Diffuse alveolar damage
dihydropyrimidine dehydrogenase deficiency
dihydropyrimidinuria
dimercaprol
diphtheria
DNA repair
drug dependence
drug misuse
drug psychosis
drug toxicity
Drug- or toxin-induced pulmonary arterial hypertension
drug-induced hepatitis
drug-induced liver injury
dysentery
ecto-ADP-ribosyltransferase 3
ecto-ADP-ribosyltransferase 3 (human)
ecto-ADP-ribosyltransferase 4
ecto-ADP-ribosyltransferase 4 (human)
ecto-ADP-ribosyltransferase 5
ecto-ADP-ribosyltransferase 5 (human)
encephalitis
encephalomyelitis
endothelial cell of hepatic sinusoid
enterocolitis
erythema multiforme
exanthem
familial hyperthyroidism due to mutations in TSH receptor
FAS-associated death domain protein
FAS-associated death domain protein (human)
fluoride poisoning
furan
gastrointestinal toxicity
Graves disease
Hand-foot syndrome
HC toxin
heavy metal poisoning
Heligmosomoides polygyrus
HELLP syndrome
hematological toxicity
hepatic porphyria
hepatic veno-occlusive disease
hepatocyte
hepatotoxicity
immune system toxicity
infant botulism
intestinal botulism
iron poisoning
kidney cortex necrosis
level of anthrax toxin receptor 1 (human) in cerebrospinal fluid
level of anthrax toxin receptor 1 in blood serum
level of anthrax toxin receptor 2 (human) in cerebrospinal fluid
level of anthrax toxin receptor 2 in blood serum
level of Ras-related C3 botulinum toxin substrate 1 (human) in cerebrospinal fluid
level of Ras-related C3 botulinum toxin substrate 2 (human) in cerebrospinal fluid
level of Ras-related C3 botulinum toxin substrate 3 (human) in cerebrospinal fluid
level of TOX high mobility group box family member 3 (human) in cerebrospinal fluid
level of TOX high mobility group box family member 3 in blood serum
malaria
mast cell
megaloblastic anemia
mercury dichloride
mercury poisoning
metabolic toxicity
musculoskeletal toxicity
mycotoxicosis
Myelitis
NC-NC
necrosis
Nematoda infectious disease
neonatal erythema toxicum
nephrotoxicity
neuromuscular junction disease
neurotoxicity
non-alcoholic steatohepatitis
nontoxic goiter
occular toxicity
ocular toxoplasmosis
oligomycin
optic neuritis
ototoxicity
PEO1
peripheral neuropathy
peripheral neurotoxicity
pneumonia caused by pseudomonas aeruginosa infection
poly [ADP-ribose] polymerase 1
poly [ADP-ribose] polymerase 1 (human)
poly [ADP-ribose] polymerase tankyrase-1
poly [ADP-ribose] polymerase tankyrase-1 (human)
preeclampsia
pregnancy disorder
promonocyte
protein mono-ADP-ribosyltransferase PARP11
protein mono-ADP-ribosyltransferase PARP11 (human)
protein mono-ADP-ribosyltransferase PARP16
protein mono-ADP-ribosyltransferase PARP16 (human)
pseudo-TORCH syndrome
psychiatric toxicity
pulmonary arterial hypertension
radiation-induced gastrointestinal mucositis
Ras-related C3 botulinum toxin substrate 1
Ras-related C3 botulinum toxin substrate 1 (human)
ras-related c3 botulinum toxin substrate 1 measurement
Ras-related C3 botulinum toxin substrate 2
Ras-related C3 botulinum toxin substrate 2 (human)
Ras-related C3 botulinum toxin substrate 3
Ras-related C3 botulinum toxin substrate 3 (human)
ras-related C3 botulinum toxin substrate 3 measurement
respiratory toxicity
response to flupirtine
retinoic acid early transcript 1E
retinoic acid early transcript 1E (human)
retinopathy of prematurity
Ritter's disease
sarcocystosis
scarlet fever
secondary Parkinson disease
Serotonin Syndrome
severe cutaneous adverse reaction
shigellosis
staphylococcal toxemia
staphyloenterotoxemia
Stevens-Johnson syndrome
subacute bacterial endocarditis
substance-induced sleep disorder
tanespimycin
teratogenicity
Thyrotoxicosis
tick paralysis
TOX high mobility group box family member 3
TOX high mobility group box family member 3 (human)
TOX high mobility group box family member 3 measurement
TOX3 (human)
toxascariasis
toxemia of pregnancy
toxic dermatosis
toxic diffuse goiter
toxic encephalopathy
toxic epidermal necrolysis
Toxic Nodular Goiter
toxic or drug-related embryofetopathy
toxicity
toxicodendron dermatitis
toxin
toxin-mediated infectious botulism
toxocariasis
Toxoplasma gondii seropositivity
toxoplasmosis
trichloroethylene-induced hypersensitivity
tumor necrosis factor receptor superfamily member 19
tumor necrosis factor receptor superfamily member 19 (human)
uremia
urothelial cell
vascular toxicity
venom
Weismann-Netter syndrome
GO: Biological Process
1,2,3-tribromopropane metabolic process
3-hydroxybenzyl alcohol metabolic process
aminoglycoside antibiotic biosynthetic process
aminoglycoside antibiotic catabolic process
anaerobic carbon tetrachloride metabolic process
bacteriocin transport
benzonitrile metabolic process
biphenyl catabolic process
biphenyl metabolic process
carbon tetrachloride catabolic process
carbon tetrachloride metabolic process
cellular detoxification
cellular detoxification of acetone
cellular detoxification of aldehyde
cellular detoxification of cadmium ion
cellular detoxification of copper ion
cellular detoxification of fluoride
cellular detoxification of hydrogen peroxide
cellular detoxification of metal ion
cellular detoxification of methylglyoxal
cellular detoxification of nitrogen compound
cellular detoxification of sulfide
cellular oxidant detoxification
cellular response to mycotoxin
cellular response to toxic substance
cyclohexylsulfamate metabolic process
cytolysis
detoxification
detoxification of aluminum ion
detoxification of arsenic-containing substance
detoxification of cadmium ion
detoxification of cobalt ion
detoxification of copper ion
detoxification of free heme
detoxification of hydrogen peroxide
detoxification of inorganic compound
detoxification of iron ion
detoxification of mercury ion
detoxification of nitrogen compound
detoxification of sulfite
detoxification of zinc ion
DNA repair
glucosinolate metabolic process
host defense response against symbiont-mediated perturbation of plasma membrane integrity
immune complex formation
immunoglobulin-mediated neutralization
killing by virus of host cell by post-segregational killing
lipopolysaccharide metabolic process
lipopolysaccharide transport
metabolite repair
methylmercury biosynthetic process
methylmercury catabolic process
negative regulation of stress response to copper ion
nitroglycerin metabolic process
oxalate transport
parathion catabolic process
pentachlorophenol catabolic process
pore complex assembly
pore formation in membrane of another organism
positive regulation of stress response to copper ion
PR-toxin biosynthetic process
regulation of stress response to copper ion
response to DDT
response to microbial phytotoxin
response to mycotoxin
response to organophosphorus
response to toxic substance
saponin biosynthetic process
saponin catabolic process
saponin metabolic process
self-resistance to endogenously produced metabolite
stress response to cadmium ion
stress response to copper ion
stress response to metal ion
stress response to nickel ion
stress response to zinc ion
symbiont-mediated non-specific activation of host T-cells
symbiont-mediated suppression of host phagosome acidification
thiocyanate metabolic process
toxic metabolite repair
toxin biosynthetic process
toxin catabolic process
toxin metabolic process
tri-n-butyltin metabolic process
trichloroethylene catabolic process
trichloroethylene metabolic process
venom-mediated perturbation of biological process
xenobiotic detoxification by transmembrane export across the cell outer membrane
xenobiotic detoxification by transmembrane export across the plasma membrane
GO: Cellular Component
apical plasma membrane urothelial plaque
central vacuole
EmrE multidrug transporter complex
endospore coat
ethanolamine degradation polyhedral organelle
low-density lipoprotein receptor complex
macrolide transmembrane transporter complex
nematocyst
NLRP3 inflammasome complex
pore complex
propanediol degradation polyhedral organelle
PTW/PP1 phosphatase complex
rhoptry
toxin-antitoxin complex
GO: Molecular Function
acyloxyacyl hydrolase activity
ATP-dependent DNA damage sensor activity
channel activity
DNA damage sensor activity
lipopolysaccharide transmembrane transporter activity
mithramycin dehydrogenase (NADPH) activity
oxalate transmembrane transporter activity
pathogen-derived receptor ligand activity
phosphatidylcholine phospholipase C activity
polyspecific organic cation:proton antiporter activity
toxic substance binding
toxin activity
toxin export channel activity
toxin sequestering activity
toxin transmembrane transporter activity
HP: Human Phenotype
Acute hepatitis
Adverse drug response
Decreased specific antibody response to vaccination
Diffuse alveolar damage
Elevated urinary succinylaminoimidazole carboxamide riboside level
Elevated urine bismuth level
Increased anti-parasite IgE antibody level
Positive CSF Toxoplasma gondii antibody positivity
Positive CSF toxoplasma gondii nucleic acid test
Positive fecal Clostridium botulinum test
Pregnancy exposure
Severe toxoplasmosis
Symptomatic seizures
Thyrotoxicosis with toxic multinodular goiter
Thyrotoxicosis with toxic single thyroid nodule
Toxemia of pregnancy
MI: Molecular Interactions
ABCB1 transporter substrate
aspgd
drugbank
material safety data sheet
reverse two hybrid
tox-r dimerization assay
toxicity attribute name
MP: Mammalian Phenotype
abnormal area postrema morphology
abnormal circumventricular organ morphology
abnormal humoral immune response
abnormal motor nerve collateral sprouting
abnormal response to brain injury
abnormal response to infection
abnormal susceptibility to Adenoviridae infection
abnormal susceptibility to bacterial infection
abnormal susceptibility to Coronaviridae infection
abnormal susceptibility to Flaviviridae infection
abnormal susceptibility to fungal infection
abnormal susceptibility to Hepadnaviridae infection
abnormal susceptibility to Herpesvirales infection
abnormal susceptibility to infection
abnormal susceptibility to infection induced morbidity/mortality
abnormal susceptibility to Ortervirales infection
abnormal susceptibility to Orthomyxoviridae infection
abnormal susceptibility to Paramyxoviridae infection
abnormal susceptibility to parasitic infection
abnormal susceptibility to Parvoviridae infection
abnormal susceptibility to Picornaviridae infection
abnormal susceptibility to Poxviridae infection
abnormal susceptibility to Retroviridae infection
abnormal susceptibility to Riboviria infection
abnormal susceptibility to Togaviridae infection
abnormal susceptibility to viral infection
abnormal trichloroethene metabolism
abnormal type II hypersensitivity reaction
aspiration pneumonia
catalepsy
decreased response to brain injury
decreased susceptibility to Adenoviridae infection
decreased susceptibility to Adenoviridae infection induced morbidity/mortality
decreased susceptibility to bacterial infection
decreased susceptibility to bacterial infection induced morbidity/mortality
decreased susceptibility to Coronaviridae infection
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
decreased susceptibility to Flaviviridae infection
decreased susceptibility to Flaviviridae infection induced morbidity/mortality
decreased susceptibility to fungal infection
decreased susceptibility to Hepadnaviridae infection
decreased susceptibility to Hepadnaviridae infection induced morbidity/mortality
decreased susceptibility to Herpesvirales infection
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
decreased susceptibility to hyperoxia-induced injury
decreased susceptibility to infection
decreased susceptibility to infection induced morbidity/mortality
decreased susceptibility to Ortervirales infection
decreased susceptibility to Ortervirales infection induced morbidity/mortality
decreased susceptibility to Orthomyxoviridae infection
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
decreased susceptibility to Paramyxoviridae infection
decreased susceptibility to Paramyxoviridae infection induced morbidity/mortality
decreased susceptibility to parasitic infection
decreased susceptibility to parasitic infection induced morbidity/mortality
decreased susceptibility to Parvoviridae infection
decreased susceptibility to Parvoviridae infection induced morbidity/mortality
decreased susceptibility to Picornaviridae infection
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
decreased susceptibility to Poxviridae infection
decreased susceptibility to Poxviridae infection induced morbidity/mortality
decreased susceptibility to Retroviridae infection
decreased susceptibility to Retroviridae infection induced morbidity/mortality
decreased susceptibility to Riboviria infection
decreased susceptibility to Riboviria infection induced morbidity/mortality
decreased susceptibility to Togaviridae infection
decreased susceptibility to Togaviridae infection induced morbidity/mortality
decreased susceptibility to type II hypersensitivity reaction
decreased susceptibility to viral infection
decreased susceptibility to viral infection induced morbidity/mortality
decreased susceptibility to virus induced diabetes
increased response to brain injury
increased susceptibility to Adenoviridae infection
increased susceptibility to Adenoviridae infection induced morbidity/mortality
increased susceptibility to bacterial infection
increased susceptibility to bacterial infection induced morbidity/mortality
increased susceptibility to Coronaviridae infection
increased susceptibility to Coronaviridae infection induced morbidity/mortality
increased susceptibility to Flaviviridae infection
increased susceptibility to Flaviviridae infection induced morbidity/mortality
increased susceptibility to fungal infection
increased susceptibility to Hepadnaviridae infection
increased susceptibility to Hepadnaviridae infection induced morbidity/mortality
increased susceptibility to Herpesvirales infection
increased susceptibility to Herpesvirales infection induced morbidity/mortality
increased susceptibility to hyperoxia-induced injury
increased susceptibility to infection
increased susceptibility to infection induced morbidity/mortality
increased susceptibility to Ortervirales infection
increased susceptibility to Ortervirales infection induced morbidity/mortality
increased susceptibility to Orthomyxoviridae infection
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
increased susceptibility to Paramyxoviridae infection
increased susceptibility to Paramyxoviridae infection induced morbidity/mortality
increased susceptibility to parasitic infection
increased susceptibility to parasitic infection induced morbidity/mortality
increased susceptibility to Parvoviridae infection
increased susceptibility to Parvoviridae infection induced morbidity/mortality
increased susceptibility to Picornaviridae infection
increased susceptibility to Picornaviridae infection induced morbidity/mortality
increased susceptibility to Poxviridae infection
increased susceptibility to Poxviridae infection induced morbidity/mortality
increased susceptibility to Retroviridae infection
increased susceptibility to Retroviridae infection induced morbidity/mortality
increased susceptibility to Riboviria infection
increased susceptibility to Riboviria infection induced morbidity/mortality
increased susceptibility to Togaviridae infection
increased susceptibility to Togaviridae infection induced morbidity/mortality
increased susceptibility to type II hypersensitivity reaction
increased susceptibility to viral infection
increased susceptibility to viral infection induced morbidity/mortality
increased susceptibility to virus induced diabetes
increased urine beta2-microglobulin level
kidney failure
optic neuropathy
oxidative stress
pharyngitis
porphyria
rhabdomyolysis
sepsis
toxic megacolon
OBA: Ontology of Biological Attributes
blood toxic metal amount
level of anthrax toxin receptor 1 in blood serum
level of anthrax toxin receptor 2 in blood serum
level of TOX high mobility group box family member 3 in blood serum
PW: Pathway Ontology
acrolein response pathway
aflatoxin metabolic pathway
Bordetella pertussis infection pathway
carbon nanotube response pathway
carboplatin response pathway
cellular senescence pathway
cerium oxide nanoparticle response pathway
cisplatin drug pathway
cisplatin response pathway
cyclophosphamide pharmacodynamics pathway
docetaxel drug pathway
metal homeostasis pathway
nanomaterial response pathway
nicotine drug pathway
nicotine pharmacodynamics pathway
oxaliplatin drug pathway
paracetamol drug pathway
paracetamol response pathway
paraquat response pathway
platinum (Pt) containing drug pathway
platinum (Pt) containing drug response pathway
procainamide response pathway
sphingolipid biosynthetic pathway
styrene degradation pathway
toxic secondary metabolite biosynthetic pathway
toxic secondary metabolite metabolic pathway
toxin and toxicant response pathway
toxoplasmosis pathway
Vibrio cholerae infection pathway
xenobiotic metabolic pathway
xenobiotics biodegradation pathway
RDO: RGD Disease Ontology
3-hydroxyisobutryl-CoA hydrolase deficiency
5 Alpha Fluorouracil Toxicity
Accelerated Idioventricular Rhythm
acquired metabolic disease
Acute Liver Failure
AIDS-Related Opportunistic Infections
alcoholic cardiomyopathy
alkaptonuria
Animal Toxoplasmosis
ascariasis
Athetosis
atypical hemolytic-uremic syndrome
bacterial exanthem
botulism
bronchiectasis
Buruli ulcer disease
Carbon Monoxide Poisoning
Cardiotoxicity
Catalepsy
central nervous system toxicity
Cerebral Toxoplasmosis
Chemical and Drug Induced Liver Injury
Chloramphenicol Toxicity
chronic toxic polyneuropathy
citrullinemia
congenital toxoplasmosis
cutaneous diphtheria
dihydropyrimidine dehydrogenase deficiency
diphtheria
disease of metabolism
drug-induced hepatitis
Drug-Related Side Effects and Adverse Reactions
Efavirenz central nervous system toxicity
encephalomyelitis
exanthem
Familial Cirrhosis
foodborne botulism
Foodborne Diseases
Formaldehyde Poisoning
fragile X-associated tremor/ataxia syndrome
galactosemia
gastrointestinal toxicity
Hearing Loss, Cisplatin-Induced
Heavy Metal Toxicity
hepatic encephalopathy
Hepatic Porphyrias
Hyperlactatemia
Idiopathic Copper Toxicosis
infant botulism
inflammatory and toxic neuropathy
inherited metabolic disorder
intestinal botulism
Larva Migrans
malaria
Massive Hepatic Necrosis
Metabolic Brain Diseases, Inborn
methemoglobinemia
Mitochondrial Cytopathy
molybdenum cofactor deficiency
MPTP Poisoning
mucositis
Mushroom Poisoning
Mycotoxicosis
Myotoxicity
Neonatal Hyperbilirubinemia
nephrotoxicity
Nervous System Lead Poisoning
Nervous System Lead Poisoning, Adult
Nervous System Lead Poisoning, Childhood
neuromuscular junction disease
nonautoimmune hyperthyroidism
nontoxic goiter
Ocular Toxoplasmosis
organophosphate-induced delayed polyneuropathy
pertussis
Plummer's disease
Poisoning
Preeclamptic Toxemia
Psychomotor Agitation
Pulmonary Arterial Hypertension
pyruvate carboxylase deficiency disease
respiratory toxicity
Ritter's disease
scarlet fever
secondary Parkinson disease
secretory diarrhea
serous labyrinthitis
Shellfish Poisoning
shigellosis
siderosis of eye
skin disease
Smoke Inhalation Injury
staphyloenterotoxemia
Stevens-Johnson syndrome
subacute bacterial endocarditis
subacute delirium
substance-induced psychosis
substance-related disorder
Taste Disorders
Thrombotic Microangiopathies
Tick Toxicoses
TORCH syndrome
toxascariasis
Toxemia
toxic diffuse goiter
toxic encephalopathy
toxic labyrinthitis
toxic maculopathy
toxic megacolon
toxic myocarditis
toxic optic neuropathy
toxic pneumonitis
toxic shock syndrome
toxicodendron dermatitis
Toxocara Canis Infection (Canine Roundworms)
toxocariasis
Toxoplasma Chorioretinitis
toxoplasmosis
uremia
vascular toxicity
Weismann-Netter Syndrome
wound botulism
UBERON: Cross-Species Anatomy
anus
elapid venom
granular gland
metanephridium
mollusc venom
mycetome
perineurium
priapium
Sertoli cell barrier
snake venom
toxactinium
venom
viper venom
VT: Vertebrate Trait Ontology
blood enzyme inhibitor amount
blood xenobiotic amount
motor nerve terminal sprouting trait
muscle arsenic amount
response to bacterial infection trait
response to Coronaviridae infection
response to fungal infection trait
response to infection trait
response to parasitic infection trait
response to viral infection trait
XCO: Experimental Condition
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
alloxan
alpidem
anti-Shiga toxin 1 beta antibody
anti-Shiga toxin 1 beta monoclonal antibody 13C4
antibody
antiserum
carbenoxolone
cytisine
diabetes-inducing chemical
digoxin
dipentyl phthalate
diphtheria toxin
hepatotoxic chemical
Kolliphor HS 15
mercury dichloride
monocrotaline
myclobutanil
nephrotoxic chemical
nicotine
PEG 400
pertussis toxin
spiroplatin
streptozotocin
teratogen
toxic substance
toxin
Toxoplasma gondii
Toxoplasma gondii cysts
PathwaysPathways with diagrams.cisplatin response pathway paracetamol drug pathway paracetamol response pathway cisplatin drug pathway cerium oxide nanoparticle response pathway |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



















